Data Dialogue with the Oncology Brothers

With Stephen Liu, MD, the Oncology Brothers review 4 major studies highlighted at the European Society for Medical Oncology (ESMO) Congress 2024, including the LAURA study, the MARIPOSA and MARIPOSA-2 studies, and the ADRIATIC study.

Rahul Gosain, MD; Rohit Gosain, MD; and Kristen Ciombor, MD, discuss recent clinical trial results from ESMO 2024, including LEAP-012 in lung cancer, KEYNOTE-811 in gastric cancer, POD1UM-303/InterAACT2 in anal cancer, and NICHE-2 in colorectal cancer, highlighting advancements in immunotherapy and targeted treatments across multiple tumor types.

Rahul Gosain, MD; Rohit Gosain, MD, and Petros Grivas, MD, examine recent oncology studies presented at ESMO 2024, including TiNivo-2, PEACE-3, and CONTACT-02, focusing on survival outcomes, combination therapies, and treatment efficacy in specific patient populations with metastatic disease.

Rahul Gosain, MD; Rohit Gosain, MD, and Paolo Tarantino, MD, analyze recent oncology trial results presented at ESMO 2024, focusing on primary endpoints, survival outcomes, and progression-free survival data across multiple studies including NATALEE, KEYNOTE-522, and DESTINYBreast-12.

Experts at World Conference on Lung Cancer 2024 analyze critical lung cancer studies including HARMONi-02, SKIPPirr, and TROPION-Lung01, examining end points such as progression-free survival, overall survival across histologies, and the potential of novel treatments like amivantamab to advance therapeutic strategies for various patient subgroups.

Following the 2024 ASCO Annual Meeting, Mark A. Lewis, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss recent updates in gastrointestinal cancer.

Following the 2024 ASCO Annual Meeting, Toni Choueiri, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss recent updates in genitourinary cancer.

Following the 2024 ASCO Annual Meeting, Erika P. Hamilton, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to review recent updates in breast cancer.

Joshua K. Sabari, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss recent updates and exciting data presented at the 2024 ASCO Annual Meeting.

Following ASCO GU 2024, Tian Zhang, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to review recent data in patients with genitourinary cancers.

Following GI ASCO 2024, Pamela Kunz, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in colorectal cancer, hepatocellular carcinoma, neuroendocrine tumor, and the role of ctDNA.

Following ASH 2023, Uma Borate, MBBS, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in myelofibrosis and acute myeloid leukemia.

Following SABCS 2023, Daniel Stover, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in HER2+ Breast Cancer.

Following the 2023 San Antonio Breast Cancer Symposium, Hope Rugo, MD joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in HR+, HER2- Breast Cancer.

Following ASH 2023, Mazyar Shadman, MD, MPH, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss key data updates in leukemia and lymphoma presented at the 2023 ASH Annual Meeting.

Following ASH 2023, Jens Hillengass, MD, PhD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss key data updates in multiple myeloma presented at the 2023 ASH Annual Meeting.

Following SABCS 2023, Eleonora Teplinsky, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss key clinical trial data updates in breast cancer.

The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Rachna Shroff, MD, to discuss recent data updates in gastrointestinal cancers from clinical trials presented at the 2023 ESMO Congress Meeting.

Join the Oncology Brothers as they work with expert Alexander Spira, MD, PhD, FACP, in reviewing key updates from ESMO 2023 centered on the management of lung cancer.

Following ESMO 2023, Erika P. Hamilton, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss recent clinical trial data in breast cancer.

The Oncology Brothers Rahul Gosain, MD, and Rohit Gosain, MD are joined by Rana McKay, MD, to review data from three key clinical trials in GU cancer following updates at ESMO 2023.

The oncology Brothers Rohit Gosain, MD, and Rahul Gosain, MD, are joined by expert Stephen Liu, MD, to review key data from the IALSC 2023 World Conference on Lung Cancer and consider their impact on clinical practice.

The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Muhammad Shaalan Beg, MD, to discuss recent data updates in gastrointestinal cancers from clinical trials presented at the 2023 ASCO Annual Meeting.

The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Toni Choueiri, MD, following the 2023 ASCO Annual Meeting to discuss recent data updates in the genitourinary cancer space.

The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Charu Aggarwal, MD, MPH, to discuss recent lung cancer data updates from clinical trials presented at the 2023 ASCO Annual Meeting.

The Oncology Brothers, joined by key opinion leader Stephanie Graff, MD, FACP, review clinical data from three key studies in breast cancer management and consider how they will impact the broader treatment landscape.